Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling. Ota N, Davies CW, Kang J, Yan D, et al. Proc Natl Acad Sci U S A 2025;122:e2501635122.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ota N, Davies CW, Kang J, Yan D, et al. Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling. Proc Natl Acad Sci U S A 2025;122:e2501635122.
PMID: 40434646